The Company will participate in the Q1FY27 earnings conference call (i.e. post earnings/quarterly call), organized by JM Financial Institutional Securities Limited on Wednesday, August ....

Ref: MHL/Sec&Legal/2026-27/29 July 28, 2026 BSE Limited National Stock Exchange of India Limited Scrip Code: 542650 Scrip Symbol: METROPOLIS Dear Sir/Madam, Sub: Intimation of earnings conference call for the quarter ended June 30, 2026 Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we would like to inform you that the Company will participate in the Q1FY27 earnings conference call (i.e. post earnings/quarterly call), organized by JM Financial Institutional Securities Limited on Wednesday, August 05, 2026 at 09:00 a.m. (IST) to discuss the financial results of the Company for the quarter ended June 30, 2026 as per details enclosed herewith. You are requested to take the above information on record. Thanking you, Yours faithfully, For Metropolis Healthcare Limited Kamlesh C Kulkarni Head - Legal & Secretarial Encl: a/a JM Financial Institutional Securities Limited invites you to Q1FY27 earnings conference call with Metropolis Healthcare Limited Wednesday, 5th August 2026 09:00 AM IST | 11:30 PM USA* | 04:30 AM UK* | 11:30 AM HK/SINGAPORE Company Participants Ms. Ameera Shah Mr. Surendran Chemmenkotil (Chairperson & Whole-time Director) (Managing Director) Mr. Sameer Patel Mr. Mohan Menon (Chief Financial Officer) (Chief Marketing Officer) Universal Dial-in: +91 22 6280 1366 | +91 22 7115 8267 Toll-free Number – International USA: UK: Singapore: Hong Kong: 1 866 746 2133 0 808 101 1573 800 101 2045 800 964 448 Please dial in 10 minutes prior to the conference schedule to ensure that you are connected in time Diamond Pass Link For further information, please contact: Mr. Amey Chalke | +91 9664976620 | amey.chalke@jmfl.com Mr. Abin Benny | +91 7710066464 | abin.benny@jmfl.com Mr. Gourav Bhama | +91 9650984629 | gourav.bhama@jmfl.com JM FINANCIAL INSTITUTIONAL SECURITIES LIMITED Corporate Identity Number: U67100MH2017PLC296081 Member of BSE Ltd. and National Stock Exchange of India Ltd. SEBI Registration Nos.: Stock Broker - INZ000163434, Research Analyst - INH000000610 Registered Office: 7th Floor, Cnergy, Appasaheb Marathe Marg, Prabhadevi, Mumbai 400 025, India. Board: +9122 6630 3030 | Fax: +91 22 6630 3488 | Email: jmfinancial.research@jmfl.com | www.jmfl.com Compliance/Grievance Officer: Ms. Ashley Johnson | Tel: +91 22 6224 1862 | Email: instcompliance@jmfl.com Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Safe harbour The proposed management discussion and comments thereof may include forward-looking statements. Forward-looking statements are statements that concern plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact. All forward looking statements are subject to risks, uncertainties and assumptions that could cause actual results of operations and financial conditions to differ materially from those contemplated by the relevant statement. All Conference Call Participants should not place undue reliance on these forward-looking statements. Registration granted by SEBI and certification from the National Institute of Securities Market (NISM) in no way guarantee performance of the intermediary or provide any assurance of returns to investors. *means the place/city is observing daylight saving time (DST) at time shown